Literature DB >> 3837045

Central anticholinergic syndrome in a child: a case report.

M Richmond, D Seger.   

Abstract

A 2-year-old boy developed classical signs and symptoms of the central anticholinergic syndrome after ingesting twenty 4-mg tablets of the antihistamine cyproheptadine (Periactin). His symptoms were dramatically reversed by the intravenous administration of physostigmine. The physiology of the anticholinergic system and physostigmine are discussed along with the indications, toxicity, and dosing of physostigmine.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3837045     DOI: 10.1016/0736-4679(85)90004-6

Source DB:  PubMed          Journal:  J Emerg Med        ISSN: 0736-4679            Impact factor:   1.484


  4 in total

1.  Safety and efficacy of cyproheptadine for treating dyspeptic symptoms in children.

Authors:  Leonel Rodriguez; Juan Diaz; Samuel Nurko
Journal:  J Pediatr       Date:  2013-02-16       Impact factor: 4.406

Review 2.  H1-receptor antagonists. Comparative tolerability and safety.

Authors:  F E Simons
Journal:  Drug Saf       Date:  1994-05       Impact factor: 5.606

3.  When Too Much Is Enough: Pediatric Cyproheptadine Overdose with Confirmatory Level.

Authors:  Terrance McGovern; Justin McNamee; Steven Marcus; Josh Kashani
Journal:  Clin Pract Cases Emerg Med       Date:  2017-07-06

4.  Effect of inhaled drugs on anxiety and depression in patients with chronic obstructive pulmonary disease: a prospective observational study.

Authors:  Min Kyung Hyun; Na Rae Lee; Eun Jin Jang; Jae-Joon Yim; Chang-Hoon Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-04-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.